Graeme I. Stevenson

Statistics

Publications

Citations

1.6K

H-Index

Active since

1985

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Graeme I. Stevenson is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and ligand binding.

Publications per year

1985–2010

Publications

L-685,458, an Aspartyl Protease Transition State Mimic, Is a Potent Inhibitor of Amyloid β-Protein Precursor γ-Secretase Activity

Mark S. Shearman, Dirk Beher, Earl E. Clarke et al. · Biochemistry · 2000 · 367 citations

Life Sciences, Neurobiology, Neuroscience +17

4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor

Paul D. Leeson, Robert W. Carling, Kevin W. Moore et al. · Journal of Medicinal Chemistry · 1992 · 187 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Novel 5-HT3 antagonists. Indole oxadiazoles

Christopher J. Swain, Robert J. Baker, Clare O. Kneen et al. · Journal of Medicinal Chemistry · 1991 · 167 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

Effect of Plasma Protein Binding on in Vivo Activity and Brain Penetration of Glycine/NMDA Receptor Antagonists

Michael Rowley, Janusz J. Kulagowski, Alan P. Watt et al. · Journal of Medicinal Chemistry · 1997 · 129 citations

Medicine, Neuroscience, Pharmacology +17

Acaricidal Activity of Eugenol Based Compounds against Scabies Mites

Cielo Pasay, Kate Mounsey, Graeme I. Stevenson et al. · PLoS ONE · 2010 · 121 citations · Full text

Pharmacy, Dermatology, Toxicology +16

1–5 of 22